Syreeta L. Tilghman

1.4k total citations
34 papers, 913 citations indexed

About

Syreeta L. Tilghman is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Syreeta L. Tilghman has authored 34 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 17 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Syreeta L. Tilghman's work include Estrogen and related hormone effects (19 papers), Cancer Cells and Metastasis (9 papers) and Cancer-related Molecular Pathways (5 papers). Syreeta L. Tilghman is often cited by papers focused on Estrogen and related hormone effects (19 papers), Cancer Cells and Metastasis (9 papers) and Cancer-related Molecular Pathways (5 papers). Syreeta L. Tilghman collaborates with scholars based in United States. Syreeta L. Tilghman's co-authors include Matthew E. Burow, John A. McLachlan, Melyssa R. Bratton, Gauri Sabnis, Lyndsay V. Rhodes, Luciana F. Macedo, Florastina Payton‐Stewart, Zhiyong Guo, Angela Brodie and Yun Qiu and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Syreeta L. Tilghman

33 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Syreeta L. Tilghman United States 15 451 300 277 248 100 34 913
Noriko Kanaya United States 17 335 0.7× 119 0.4× 238 0.9× 113 0.5× 70 0.7× 27 715
Patrizia Miodini Italy 18 419 0.9× 399 1.3× 331 1.2× 322 1.3× 29 0.3× 42 1.0k
Sara Antonia Li United States 21 680 1.5× 590 2.0× 262 0.9× 213 0.9× 116 1.2× 38 1.2k
Joshua D. Liao United States 14 454 1.0× 72 0.2× 175 0.6× 169 0.7× 45 0.5× 22 858
Jiarong Cheng China 19 601 1.3× 469 1.6× 376 1.4× 170 0.7× 29 0.3× 39 1.4k
Jonathan J. Li United States 24 807 1.8× 654 2.2× 291 1.1× 240 1.0× 136 1.4× 56 1.5k
Elise F. Saunier United States 15 675 1.5× 215 0.7× 313 1.1× 235 0.9× 29 0.3× 19 1.1k
Shuping Zhong United States 20 1.3k 2.9× 139 0.5× 239 0.9× 331 1.3× 36 0.4× 43 1.7k
Anna Kakehashi Japan 20 463 1.0× 63 0.2× 151 0.5× 250 1.0× 94 0.9× 89 1.0k
Maria Simonsson Sweden 15 519 1.2× 151 0.5× 261 0.9× 221 0.9× 13 0.1× 27 922

Countries citing papers authored by Syreeta L. Tilghman

Since Specialization
Citations

This map shows the geographic impact of Syreeta L. Tilghman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Syreeta L. Tilghman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Syreeta L. Tilghman more than expected).

Fields of papers citing papers by Syreeta L. Tilghman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Syreeta L. Tilghman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Syreeta L. Tilghman. The network helps show where Syreeta L. Tilghman may publish in the future.

Co-authorship network of co-authors of Syreeta L. Tilghman

This figure shows the co-authorship network connecting the top 25 collaborators of Syreeta L. Tilghman. A scholar is included among the top collaborators of Syreeta L. Tilghman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Syreeta L. Tilghman. Syreeta L. Tilghman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Boué, Stephen M., et al.. (2023). Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1. Nutrients. 15(7). 1632–1632. 4 indexed citations
3.
Tilghman, Syreeta L., et al.. (2021). Mammospheres of letrozole-resistant breast cancer cells enhance breast cancer aggressiveness. Oncology Letters. 22(2). 620–620. 8 indexed citations
4.
Bratton, Melyssa R., et al.. (2021). Acquisition of Letrozole Resistance Through Activation of the p38/MAPK Signaling Cascade. Anticancer Research. 41(2). 583–599. 8 indexed citations
5.
Llopis, Shawn D., et al.. (2021). Quantitative Proteomic Profiling Identifies a Potential Novel Chaperone Marker in Resistant Breast Cancer. Frontiers in Oncology. 11. 540134–540134. 5 indexed citations
6.
Tilghman, Syreeta L., et al.. (2020). Abstract 4116: A novel phytoalexin, glyceollins, trigger anti-proliferative and apoptotic effects in aromatase inhibitor resistant breast cancer cells. Cancer Research. 80(16_Supplement). 4116–4116. 1 indexed citations
7.
Payton‐Stewart, Florastina, et al.. (2014). Benzimidazoles diminish ERE transcriptional activity and cell growth in breast cancer cells. Biochemical and Biophysical Research Communications. 450(4). 1358–1362. 14 indexed citations
8.
Tilghman, Syreeta L., Ian K. Townley, Qiu Zhong, et al.. (2013). Proteomic Signatures of Acquired Letrozole Resistance in Breast Cancer: Suppressed Estrogen Signaling and Increased Cell Motility and Invasiveness. Molecular & Cellular Proteomics. 12(9). 2440–2455. 51 indexed citations
9.
Burow, Matthew E., Lyndsay V. Rhodes, Patrick P. Carriere, et al.. (2013). In Vitro and In Vivo evaluation of novel anticancer agents in triple negative Breast Cancer Models. Journal of Health Care for the Poor and Underserved. 24(1A). 104–111. 10 indexed citations
10.
Tilghman, Syreeta L., Lyndsay V. Rhodes, Melyssa R. Bratton, et al.. (2013). Phytoalexins, miRNAs and Breast Cancer: A Review of Phytochemical-mediated miRNA Regulation in Breast Cancer. Journal of Health Care for the Poor and Underserved. 24(1A). 36–46. 21 indexed citations
11.
Martin, Elizabeth C., Melyssa R. Bratton, Yun Zhu, et al.. (2012). Insulin-Like Growth Factor-1 Signaling Regulates miRNA Expression in MCF-7 Breast Cancer Cell Line. PLoS ONE. 7(11). e49067–e49067. 20 indexed citations
12.
Bratton, Melyssa R., James W. Antoon, Daniel E. Frigo, et al.. (2012). Gαo potentiates estrogen receptor α activity via the ERK signaling pathway. Journal of Endocrinology. 214(1). 45–54. 17 indexed citations
13.
Rhodes, Lyndsay V., Melyssa R. Bratton, Yun Zhu, et al.. (2011). Effects of SDF-1–CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells. Experimental Cell Research. 317(18). 2573–2581. 30 indexed citations
14.
McLachlan, John A., Syreeta L. Tilghman, Matthew E. Burow, & Melyssa R. Bratton. (2011). Environmental signaling and reproduction: A comparative biological and chemical perspective. Molecular and Cellular Endocrinology. 354(1-2). 60–62. 13 indexed citations
15.
Rhodes, Lyndsay V., Syreeta L. Tilghman, Stephen M. Boué, et al.. (2011). Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer. Oncology Letters. 3(1). 163–171. 45 indexed citations
16.
Tilghman, Syreeta L., Gauri Sabnis, & Angela Brodie. (2010). Upregulation of AIB1, aromatase and ERα provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survival. Hormone Molecular Biology and Clinical Investigation. 3(1). 357–366. 11 indexed citations
17.
Tilghman, Syreeta L., Stephen M. Boué, & Matthew E. Burow. (2010). Glyceollins, a Novel Class of Antiestrogenic Phytoalexins. 2(4). 155–160. 11 indexed citations
18.
Payton‐Stewart, Florastina, Stephen M. Boué, Steven Elliott, et al.. (2010). Glyceollin I enantiomers distinctly regulate ER-mediated gene expression. Steroids. 75(12). 870–878. 29 indexed citations
19.
Rhodes, Lyndsay V., Shannon E. Muir, Steven Elliott, et al.. (2009). Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence. Breast Cancer Research and Treatment. 121(2). 293–300. 91 indexed citations
20.
Brodie, Angela, Danijela Jelovac, Luciana F. Macedo, et al.. (2005). Therapeutic Observations in MCF-7 Aromatase Xenografts. Clinical Cancer Research. 11(2). 884s–888s. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriko Kanaya Breakdown of academic impact, for papers by Patrizia Miodini Breakdown of academic impact, for papers by Sara Antonia Li Breakdown of academic impact, for papers by Joshua D. Liao Breakdown of academic impact, for papers by Jiarong Cheng Breakdown of academic impact, for papers by Jonathan J. Li Breakdown of academic impact, for papers by Elise F. Saunier Breakdown of academic impact, for papers by Shuping Zhong Breakdown of academic impact, for papers by Anna Kakehashi Breakdown of academic impact, for papers by Maria Simonsson
Rankless by CCL
2026